The short answer
Paracetamol hepatotoxicity arises when a reactive metabolite depletes hepatic glutathione. The established antidote is N-acetylcysteine, which supplies cysteine for glutathione resynthesis rather than supplying glutathione itself â the practical demonstration, at scale, that cysteine is the limiting substrate.
Key facts
- Reactive metabolite
- NAPQI
- Normally handled by
- Conjugation with glutathione
- Toxicity arises when
- Glutathione is depleted
- Antidote
- N-acetylcysteine
- What it supplies
- Cysteine, not glutathione
- Review
- James 2003 (PMID 14625346)
- Analogue work
- Khayyat 2016 (PMID 26602168)
How the toxicity arises
Most paracetamol is cleared by conjugation to inactive products. A minor fraction is oxidised to a reactive metabolite, N-acetyl-p-benzoquinone imine, which is electrophilic and damaging. Under ordinary conditions glutathione conjugates it immediately and the amount formed is small enough that this is unproblematic.
What changes in overdose
The main conjugation routes saturate, so a larger proportion goes down the oxidative path and more reactive metabolite is produced. Glutathione is consumed conjugating it, and once the hepatic pool is substantially depleted the metabolite reaches cellular proteins instead. James reviewed this sequence in Drug Metabolism and Disposition in 2003.
Research material referenced
Glutathione 1500mg, third-party HPLC tested
Why glutathione depletion is the mechanism rather than a marker
The metabolite is not toxic because glutathione fell; it is toxic because nothing is left to conjugate it. Glutathione is the defence being exhausted, which makes this one of the clearest cases in pharmacology where a molecule's protective role is demonstrated by what happens in its absence.
Why the antidote supplies cysteine
N-acetylcysteine is a cysteine donor. It works by replenishing the substrate that limits glutathione synthesis, allowing the cell to rebuild its own pool. It does not supply glutathione. That choice is the practical demonstration of a point argued elsewhere on this site on theoretical grounds. Cysteine is the limiting substrate, so supplying cysteine addresses the actual constraint.
Why not simply give glutathione
Because the cell needs it inside, and glutathione is synthesised intracellularly through a regulated two-step pathway. Supplying the finished tripeptide externally faces the same difficulty described in this site's oral bioavailability article, while supplying cysteine feeds the existing route. The clinical world settled this question decades ago by choosing the precursor.
What is emphatically not being suggested
Paracetamol overdose is a medical emergency managed in hospital with monitoring and established protocols. Nothing here is guidance of any kind. N-acetylcysteine in that setting is a licensed medicine administered clinically, and nothing supplied on this site is a treatment for anything or has any role in any emergency.
Frequently asked questions
Why does paracetamol damage the liver in overdose?
The main clearance routes saturate, more reactive metabolite forms, and once glutathione is depleted there is nothing left to conjugate it.
Why is the antidote cysteine rather than glutathione?
Cysteine is the substrate limiting glutathione synthesis, so supplying it lets the cell rebuild its own pool through the regulated intracellular pathway.
What does this demonstrate?
That cysteine, not glutathione, is the limiting input. A point argued theoretically elsewhere and shown practically here.
Continue researching
Related guides and reference material.
Primary sources & clinical trials
Published papers, trial registrations, regulator pages and company announcements. Links open the original.
- PubMedJames LP et al., Acetaminophen-induced hepatotoxicity. Drug Metab Dispos 2003 (PMID 14625346)pubmed.ncbi.nlm.nih.gov
- PubMedKhayyat A et al., N-acetylcysteine amide, a promising antidote for acetaminophen toxicity. Toxicol Lett 2016 (PMID 26602168)pubmed.ncbi.nlm.nih.gov
- PubMedSalinas AE, Wong MG, Glutathione S-transferases: a review. Curr Med Chem 1999 (PMID 10101214)pubmed.ncbi.nlm.nih.gov
Written and published by UK Peptides, the trading name of AURYXRESEARCH LTD (company 17388727, registered in England and Wales).
Questions or a correction? Email hello@ukpeptides.org or call +44 7426 987848.
More Glutathione articles
- An Enzyme Family That Uses Glutathione as a ReagentGSTs attach glutathione to electrophilic compounds, making them water-soluble and excretable. It is enzymatic chemistry, not radical scavenging.
- Four Jobs, Only One of Which the Label DescribesRedox buffer, enzyme substrate, conjugation reagent and proposed amino acid carrier. The common label captures roughly a quarter of it.
- Kidney and Intestine, and Why Position MattersThe cycle enzymes are concentrated in transporting epithelia. Cornell and Meister found they differ between crypt and villus tip cells in one tissue.
- What Is Glutathione? The Bond That Makes It UnusualA tripeptide at 307.33 Da joined by an unusual gamma-glutamyl bond. The cell's principal thiol antioxidant, and why ribosomes cannot make it.
- Is Glutathione a Peptide? Yes, and an Unusual OneThree amino acids joined by peptide bonds - so yes. But one of those bonds is gamma-linked, which puts it outside most peptide generalisations.